Advisory Services Network’s Maravai LifeSciences MRVI Stock Holding History

Advisory Services Network’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,483	Closed	-$7.03K	–	3700
2026 Q1	$7.03K	Buy	+2,483	New	+$8.42K	﹤0.01%	3723
2025 Q4	–	Sell	-1,549	Closed	-$4.45K	–	3342
2025 Q3	$4.45K	Buy	+1,549	New	+$3.96K	﹤0.01%	3566
2023 Q2	–	Sell	-10	Closed	-$140	–	2790
2023 Q1	$140	Hold	10	–	–	﹤0.01%	3883
2022 Q4	$143	Buy	+10	New	+$157	﹤0.01%	3889
2021 Q3	–	Sell	-36	Closed	-$2K	–	2528
2021 Q2	$2K	Buy	+36	New	+$1.4K	﹤0.01%	3336
2021 Q1	–	Sell	-21	Closed	-$1K	–	2333
2020 Q4	$1K	Buy	+21	New	+$585	﹤0.01%	3162

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Advisory Services Network's MRVI Position: Q2 2026 in Review

Advisory Services Network sold out of Maravai LifeSciences (MRVI) in Q2 2026, closing a stake of 2,483 shares — an estimated $7.03K sold.

Advisory Services Network first reported a position in MRVI in Q4 2020 and held it in 6 quarters. The position peaked at $7.03K in Q1 2026. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Advisory Services Network reported no remaining Maravai LifeSciences position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 2,483 Maravai LifeSciences shares in Q2 2026, an estimated $7.03K.
Advisory Services Network first reported a position in Maravai LifeSciences in Q4 2020 and held it in 6 quarters.
Advisory Services Network's Maravai LifeSciences position peaked at $7.03K in Q1 2026.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.